Exor NV (NL:EXO)
:EXO
Want to see NL:EXO full AI Analyst Report?
Top Page
Exor
(EXO)
Select Model
Select Model
Rating:54Neutral
Price Target:
€68.00
▼(-2.79% Downside)
Action:ReiteratedDate:04/02/26
The score is held back primarily by volatile financial performance (sharp 2025 downturn and inconsistent cash/earnings alignment) and bearish technical signals (price below key moving averages with negative MACD). Offsetting factors include a strengthened liquidity position and shareholder-friendly buybacks highlighted on the earnings call, while valuation signals are limited by the reported P/E of 0.0 and only a modest dividend yield.
Positive Factors
Balance sheet & liquidity
Exor’s materially strengthened liquidity and reduced leverage deliver durable financial flexibility. Low loan‑to‑value, cash buffers and an extended credit line cut refinancing risk, enable patient capital deployment, support buybacks/dividends and allow multi‑year support for portfolio turnarounds.
Negative Factors
NAV decline
A material NAV contraction in 2025 highlights Exor’s sensitivity to large operating holdings. Persistent NAV volatility undermines predictability of investor returns, can sustain a wide discount to intrinsic value, and reduces the margin for error when management deploys capital or supports underperforming assets.
Read all positive and negative factors
Positive Factors
Negative Factors
Balance sheet & liquidity
Exor’s materially strengthened liquidity and reduced leverage deliver durable financial flexibility. Low loan‑to‑value, cash buffers and an extended credit line cut refinancing risk, enable patient capital deployment, support buybacks/dividends and allow multi‑year support for portfolio turnarounds.
Read all positive factors
Exor (EXO) vs. iShares MSCI Netherlands ETF (EWN)
Market Cap
€22.29B
Dividend Yield0.68%
Average Volume (3M)221.98K
Price to Earnings (P/E)―
Beta (1Y)1.12
Revenue GrowthN/A
EPS GrowthN/A
CountryNL
Employees23
SectorIndustrials
Sector Strength72
IndustryAuto - Manufacturers
Share Statistics
EPS (TTM)N/A
Shares Outstanding207,779,750
10 Day Avg. Volume162,632
30 Day Avg. Volume221,981
Financial Highlights & Ratios
PEG Ratio0.03
Price to Book (P/B)0.45
Price to Sales (P/S)14.44
P/FCF Ratio5.25
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price Target
€106.50Price Target Upside52.26% Upside
Rating ConsensusModerate Buy
Number of Analyst Covering2
EPS Forecast (FY)1.46
Revenue Forecast (FY)N/A
Exor Business Overview & Revenue Model
Company Description
Exor N.V., together with its subsidiaries, engages in the luxury goods, automotive, agricultural equipment, construction equipment, commercial vehicles, and professional football businesses. The company designs, engineers, produces, and sells luxu...
How the Company Makes Money
Exor makes money primarily as an investment holding company through: (1) Dividends and profit distributions received from its portfolio companies (e.g., cash dividends declared by listed and unlisted operating subsidiaries/associates). (2) Capital...
Exor Earnings Call Summary
Earnings Call Date:Mar 23, 2026
(Q4-2025)
| % Change Since: |
Next Earnings Date:Sep 09, 2026
Earnings Call Sentiment Neutral
The call presented a balanced picture: strong internal actions and positive developments (Lingotto’s strong performance, meaningful buybacks, a fortified balance sheet, and improving execution at Philips) are offset by significant headwinds from major holdings (NAV decline driven by Ferrari, Stellantis and CNH), a very large discount to NAV, and ongoing operational challenges at key portfolio companies. Management emphasizes prudence, liquidity, and patient capital allocation entering a difficult 2026.Positive Updates
Lingotto Reaches EUR 10 Billion AUM and Strong Performance
Lingotto reached roughly EUR 10 billion in assets under management and delivered an outstanding performance, with Lingotto rising ~40% in 2025, driven by its intersection/public strategy and selective third-party capital.
Negative Updates
NAV Per Share Decline in 2025
Net asset value (NAV) per share fell from EUR 178 at the start of the year to EUR 164.4 at year-end (a decline of ~7.6% or about EUR 13.6 per share), driven mainly by weak performance of several large holdings.
Read all updates
Q4-2025 Updates
Positive
Negative
Lingotto Reaches EUR 10 Billion AUM and Strong Performance
Lingotto reached roughly EUR 10 billion in assets under management and delivered an outstanding performance, with Lingotto rising ~40% in 2025, driven by its intersection/public strategy and selective third-party capital.
Read all positive updates
Company Guidance
Management guided a cautious, liquidity‑first approach for 2026 after a heavy 2025 of portfolio reset: NAV per share fell from EUR 178 to EUR 164.4 (a EUR 25/share hit mainly from Ferrari, Stellantis and CNH), Lingotto delivered +40% and reached ~EUR/USD 10 billion AUM, and Exor completed ~EUR 2.5 billion of buybacks over recent years (including EUR 1 billion in 2025) buying nearly 15% of shares at >50% discounts; balance‑sheet metrics cited included loan‑to‑value down to 6.9%, free cash flow/dividend ~6x, cash of EUR 1.4 billion, a doubled EUR 1.1 billion credit facility, EUR 600 million refinanced (maturing 2035), a $170 million private‑placement payment coming up, and expected ~EUR 3–4 billion of additional resources as announced transactions close (Iveco transactions valued at EUR 5.3 billion; divestments returning ~1.4x on cost). Priorities are to focus on larger holdings, simplify the portfolio, preserve capital and deploy capital with discipline (remaining interested in healthcare, luxury and technology and willing to take >5% positions where appropriate).Exor Financial Statement Overview
Summary
Income Statement
46
Neutral
Balance Sheet
62
Positive
Cash Flow
55
Neutral
| Breakdown | Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 |
|---|---|---|---|---|---|
Income Statement | |||||
| Total Revenue | 1.04B | 1.90B | 45.41B | 41.84B | 33.62B |
| Gross Profit | 1.02B | 1.89B | 11.97B | 9.51B | 7.64B |
| EBITDA | -4.57B | 17.39B | 8.03B | 5.96B | 1.47B |
| Net Income | -3.79B | 14.67B | 4.19B | 4.23B | 1.72B |
Balance Sheet | |||||
| Total Assets | 37.13B | 42.46B | 94.78B | 83.70B | 91.11B |
| Cash, Cash Equivalents and Short-Term Investments | 1.39B | 153.00M | 8.66B | 13.51B | 7.70B |
| Total Debt | 0.00 | 4.09B | 40.22B | 48.05B | 28.95B |
| Total Liabilities | 3.89B | 4.25B | 61.65B | 54.03B | 66.74B |
| Stockholders Equity | 33.24B | 38.21B | 23.27B | 20.63B | 16.76B |
Cash Flow | |||||
| Free Cash Flow | 2.86B | 47.00M | 1.22B | 2.47B | 2.22B |
| Operating Cash Flow | 2.86B | 47.00M | 4.03B | 4.92B | 4.18B |
| Investing Cash Flow | 24.00M | -58.00M | -8.73B | -4.10B | -29.59B |
| Financing Cash Flow | -1.63B | -56.00M | 2.11B | 2.13B | -2.19B |
Exor Technical Analysis
Neutral
69.95
Price Trends
69.57
Positive
70.74
Negative
76.79
Negative
Market Momentum
0.17
Negative
57.27
Neutral
89.17
Negative
Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For NL:EXO, the sentiment is Neutral. The current price of 69.95 is above the 20-day moving average (MA) of 66.72, above the 50-day MA of 69.57, and below the 200-day MA of 76.79, indicating a neutral trend. The MACD of 0.17 indicates Negative momentum. The RSI at 57.27 is Neutral, neither overbought nor oversold. The STOCH value of 89.17 is Negative, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Neutral sentiment for NL:EXO.
Exor Peers Comparison
UnderperformOutperform
Sector (63)
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
77 Outperform | €2.40B | 14.29 | 25.42% | 2.44% | 11.67% | 36.03% | |
75 Outperform | €4.73B | 7.24 | 15.92% | 4.27% | -3.32% | 15.52% | |
74 Outperform | €2.60B | 11.48 | 11.89% | 2.69% | 3.64% | -22.13% | |
66 Neutral | €2.64B | 15.23 | 14.59% | 2.85% | -2.02% | 24.14% | |
63 Neutral | $10.79B | 15.43 | 7.44% | 2.01% | 2.89% | -14.66% | |
62 Neutral | €3.34B | 20.51 | 6.13% | 4.08% | -4.31% | -50.34% | |
54 Neutral | €22.29B | -1.19 | ― | 0.68% | ― | ― |
* Industrials Sector Average
NL:EXO
Exor
69.95
-8.15
-10.44%
NL:AALB
Aalberts Industries N.V.
31.44
5.60
21.65%
NL:ARCAD
Arcadis NV
31.62
-8.29
-20.76%
NL:BAMNB
Koninklijke Bam Groep NV
9.54
4.62
93.80%
NL:HEIJM
Heijmans N.V.
86.95
48.71
127.38%
NL:VPK
Royal Vopak NV
42.66
5.59
15.08%
Glossary
BuyA stock rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock is likely to deliver higher returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldA stock rated as a "Hold" is expected to perform in line with the overall market or a specific benchmark. This rating indicates that the stock is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellA stock rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock may deliver lower returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
Disclaimer
This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.